Pharmabiz

Rhythm Pharmaceuticals’ setmelanotide receives US FDA approval to treat patients living with acquired hypothalamic obesity

Rhythm Pharmaceuticals’ setmelanotide receives US FDA approval to treat patients living with acquired hypothalamic obesity: Boston Saturday, March 21, 2026, 18:00 Hrs [IST] Rhyt ...
Pharmabiz

Macau Drug Administration approves Belief Pharmaceuticals’ haemophilia B gene therapy drug, Popidacoji injection

Macau Drug Administration approves Belief Pharmaceuticals’ haemophilia B gene therapy drug, Popidacoji injection: Shanghai, China Saturday, March 21, 2026, 17:00 Hrs [IST] Belie ...
Pharmabiz

Kythera Labs inks partnership with Doceree to improve data-driven engagement with healthcare professionals

Kythera Labs inks partnership with Doceree to improve data-driven engagement with healthcare professionals: Franklin, Tennessee Saturday, March 21, 2026, 16:00 Hrs [IST] Kythera L ...
Pharmabiz

Clariant expands pharmaceutical-grade PEG manufacturing into North America with Texas facility

Clariant expands pharmaceutical-grade PEG manufacturing into North America with Texas facility: Charlotte, North Carolina Saturday, March 21, 2026, 15:00 Hrs [IST] Clariant is exp ...
Pharmabiz

Sun Pharma introduces semaglutide injection under the brand names, Noveltreat and Sematrinity in India

Sun Pharma introduces semaglutide injection under the brand names, Noveltreat and Sematrinity in India: Our Bureau, Mumbai Saturday, March 21, 2026, 14:15 Hrs [IST] Sun Pharmaceut ...
Pharmabiz

New PRIME tools to accelerate development of medicines in the EU

New PRIME tools to accelerate development of medicines in the EU: Amsterdam, The Netherlands Saturday, March 21, 2026, 14:00 Hrs [IST] EMA launched three major new features of PRI ...
Pharmabiz

Dr Reddy’s Labs launches India’s first DCGI-approved semaglutide injection ‘Obeda’ for type 2 diabetes

Dr Reddy’s Labs launches India’s first DCGI-approved semaglutide injection ‘Obeda’ for type 2 diabetes: Our Bureau, Mumbai Saturday, March 21, 2026, 13:30 Hrs [IST] Dr Red ...
Pharmabiz

Biohaven completes patient enrolment in phase 2 obesity study with taldefgrobep alfa, a novel myostatin-activin pathway inhibitor

Biohaven completes patient enrolment in phase 2 obesity study with taldefgrobep alfa, a novel myostatin-activin pathway inhibitor: New Haven, Connecticut Saturday, March 21, 2026, ...
Pharmabiz

US FDA approves Novo Nordisk’s Wegovy HD to reduce excess body weight and maintain weight reduction

US FDA approves Novo Nordisk’s Wegovy HD to reduce excess body weight and maintain weight reduction: Bagsværd, Denmark Saturday, March 21, 2026, 12:00 Hrs [IST] Novo Nordisk, a ...
Pharmabiz

GSK’s Lynavoy receives US FDA approval for cholestatic pruritus in patients with primary biliary cholangitis

GSK’s Lynavoy receives US FDA approval for cholestatic pruritus in patients with primary biliary cholangitis: London, UK Saturday, March 21, 2026, 11:00 Hrs [IST] GSK plc announ ...
Pharmabiz

Novartis inks agreement with Synnovation Therapeutics to acquire a pan-mutant-selective PI3Ka inhibitor

Novartis inks agreement with Synnovation Therapeutics to acquire a pan-mutant-selective PI3Ka inhibitor: Basel Saturday, March 21, 2026, 10:00 Hrs [IST] Novartis announced that it ...
Pharmabiz

Eppendorf introduces SpinPro centrifuge series to streamline life science research

Eppendorf introduces SpinPro centrifuge series to streamline life science research: Hamburg, Germany Saturday, March 21, 2026, 09:00 Hrs [IST] Eppendorf, a leading international l ...